Bendamustine hydrochloride is a bifunctional chemotherapeutic agent with structurally similar to alkylating agents and purine analogues. However, it has a distinct mechanism of action. This agent, alone or in combination with other chemotherapeutic agents, has been shown to produce good clinical efficacy and acceptable tolerability in patients with Chronic Lymphocytic Leukaemia (CLL), Non-Hodgkin's Lymphoma (NHL) and Multiple myeloma (MM).
Indications:
GenericName | Strength | Standard | Type | Packing | Pack Size |
Bendamustine | 100 mg | IP | INJ | Vial | 1 Vial |